← Back to Clinical Trials
Recruiting NCT06946784

NCT06946784 LIFE-TB ; Long-Term Impacts on Lung Health and Life After Tuberculosis in Korea

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06946784
Status Recruiting
Phase
Sponsor Yonsei University
Condition Tuberculosis
Study Type OBSERVATIONAL
Enrollment 360 participants
Start Date 2025-02-25
Primary Completion 2031-12-31

Eligibility & Interventions

Sex All sexes
Min Age 19 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 360 participants in total. It began in 2025-02-25 with a primary completion date of 2031-12-31.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This is a prospective, multicenter observational cohort study aimed at establishing a nationwide post-TB lung disease registry in Korea. The study will enroll adult participants either undergoing treatment for pulmonary tuberculosis or with a history of treated TB. Over a five-year follow-up period, the study will assess the long-term health consequences of TB, focusing on respiratory symptoms, radiological changes, pulmonary function, and quality of life.

Eligibility Criteria

Inclusion Criteria: * Age ≥19 years * Diagnosed with pulmonary TB and either initiating or undergoing treatment or history of treated pulmonary TB Exclusion Criteria: * Age \<19 years * Extrapulmonary TB without lung involvement * Refusal to provide informed consent

Frequently Asked Questions

Who can join the NCT06946784 clinical trial?

This trial is open to participants of all sexes, aged 19 Years or older, studying Tuberculosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06946784 currently recruiting?

Yes, NCT06946784 is actively recruiting participants. Visit ClinicalTrials.gov or contact Yonsei University to inquire about joining.

Where is the NCT06946784 trial being conducted?

This trial is being conducted at Seoul, South Korea.

Who is sponsoring the NCT06946784 clinical trial?

NCT06946784 is sponsored by Yonsei University. The trial plans to enroll 360 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology